September 28, 2016 – – Parker Waichman LLP, a national law firm that has spent many years fighting to ensure that the heroes and survivors of the September 11th terrorist attacks are never forgotten, notes that there have been concerns regarding asthma control in adolescents and teenagers who were diagnosed with asthma following the attacks and who were exposed to the attacks at the World Trade Center. According to a report dated September 22, 2016 in the journal Pediatric Research, the study reviewed both asthma and asthma control for 10-11 years following the attacks in exposed adolescents and teens.

Of note, the reauthorized James L. Zadroga 9/11 Health and Compensation Act passed in December 2015 will provide adequate funding and benefits to sufficiently care for the first responders and survivors of the 9/11 terrorist attacks throughout their lifetimes. The reauthorization extends the Zadroga Act’s programs. The World Trade Center (WTC) Health Program will continue to provide medical treatment and monitoring and has been extended for another 75 years to 2090 with $3.5 billion in funding to monitor and care for 73,000 responders and survivors. The Victims Compensation Fund (VCF) has been extended for another five years to 2021 with $4.6 billion in funding.

The World Trade Center Health Registry Adolescent Wave 3 Survey, conducted in 2011-2012, collected data on adolescent asthma diagnosed by a physician following the September 11, 2001 attacks. The data included the level of asthma control—based on modified National Asthma Education and Prevention Program criteria—and also looked at probable mental health conditions and behavior problems. Parents also reported healthcare needs and 9/11-exposures. A so-called “logistic regression” approach was utilized to determine the ties between asthma, the level of asthma control, 9/11-exposure, mental health and behavioral problems, and unmet healthcare needs, according to the Pediatric Research report.

The researchers of the study entitled, “Asthma Control in Adolescents 10 to 11 Years after Exposure to the World Trade Center Disaster,” concluded that comprehensive care of post-9/11 asthma in adolescents should include management of mental health-related comorbidities. Parker Waichman notes that, regarding the 9/11 attack exposure and related illnesses, there is no statute of limitation on children; therefore, kids do not age out of statute of limitation protection. This means that, if an individual was 10 years old at the time of the attacks and developed asthma as a result of the attacks and is 25 years old today, under most circumstances, that individual has not aged out of compensation.

“The firm is pleased that the innocent children who were exposed to the trauma and toxins of the World Trade Center terrorist attacks are eligible for coverage and that research confirms the physical and psychological damage associated with the attacks,” said Keith Gitman, Managing Attorney at Parker Waichman. “The firm has fought long and hard to ensure all those entitled to benefits receive them, including children.”

In the years following the attacks, researchers determined that the thick plume of dust and debris that hovered over lower Manhattan contained a toxic mix of compounds, including asbestos; pulverized cement; polychlorinated biphenyls (PCBs); benzene; dioxin; glass fibers; gypsum; jet fuel; heavy metals, including lead and other chemicals; irritants; toxins; and carcinogens. Many residents, workers, and rescue and recovery workers exposed to these toxins have been diagnosed with various illnesses, including aerodigestive disorders such as asthma and chronic obstructive pulmonary disease (COPD); gastroesophageal reflux disease (GERD); and mental health issues, including depression and anxiety disorder associated with the trauma of exposure to the attacks. Over 90 health conditions, including 60 types of cancer, are believed to be a direct result of the toxic dust those in the area inhaled.

Parker Waichman emphasizes the importance of the VCF and the WTC Health Program and is proud to have fought alongside Ground Zero residents, workers, first responders, and other survivors and advocates, to help ensure passage of Zadroga Act amendments. The firm vows to continue its efforts to safeguard all those, including children, who were exposed to Ground Zero’s toxic cloud and the trauma of the attacks, and ensure that all of the deserved Zadroga Act compensation is received. To determine eligibility for compensation under the Act, especially concerning asthma and statute of limitation for teens exposed at the site, or for assistance with a claim, please visit the Parker Waichman’s website or call 1-800-LAW-INFO (1-800-529-4636).

###

Contact Parker Waichman LLP:

Parker Waichman
516-466-6500
info@yourlawyer.com
6 Harbor Park Drive Port Washington, NY 11050

ReleaseID: 60012612

September 28, 2016 – – Reginald Williams Realty, LLC, a business in Mount Pleasant, SC, has released a home valuation tool to give a potential home seller an idea of a price range that the home may sell for. To provide this price range, some information is obtained by public records. However, for detailed accuracy, people are encouraged to contact Reginald Williams Realty.

Reginald Williams, owner and founder of Reginald Williams Realty, LLC, says: “Are you thinking about selling your house? Then what would be the price range that you would put it on the market for? That’s a good question. Do you want to know the price range that your home will sell for, but not a ton of realtors trying to list your property? We offer a free, instant market analysis online to give you a general idea of what the property is worth.”

There are numerous online home valuation sites out there. What sets Reginald Williams Realty apart, however, is that the business clearly explains to people that the tool is for guidelines only. Rather than telling their clients that the valuation is 100% accurate, they encourage people to contact their offices in order to have their home valued properly. Using the information from the tool, therefore, is for information purposes only.

“There has been quite a lot of media attention about the lack of accuracy in home valuation tools,” adds Reginald Williams. “This is mainly due to the fact that no online algorithm can determine factors such as neighborhood conditions, condition of the property, how it is decorated, and the various other factors that come into play when determining how much a home is worth. But what it can do is give someone a general idea. The question ‘how much is my house worth?’ can only be answered by a professional.”

Through the tool, Reginald Williams Realty, LLC hopes to give people at least the information they need to determine whether or not to put their house on the market. If they do decide to put the home for sale and want more detailed information, they can consult with the realty company.

###

Contact Reginald Williams Realty, LLC:

Reginald Williams
8439262910
reginaldw@kw.com
496 Bramson Court Ste 200
Mount Pleasant, SC 29464

ReleaseID: 60012343

September 28, 2016 – – TheProductLawyers.com reports on an article by NPR indicating that women who need care involved with ovarian or breast cancer may not get the care they need.

According to the article, a study found that many marketplace health plan documents contain language that allows them to refuse to cover a range of services that are used more often by women. The researchers reviewed plans’ detailed documents and identified six types of excluded services, including gene mutation testing, that could have a disproportionate impact on women’s health care, the article said.

The information is especially relevant given the growing number of lawsuits that have been filed against Johnson & Johnson claiming that their talcum powder products cause ovarian cancer. These cases follow numerous studies done over the last 45 years that have found that women who use baby powder as a feminine hygiene product are more likely to develop ovarian cancer. Johnson & Johnson has maintained denial in these claims and has previously stated that there is no link between talcum powder and ovarian cancer. The company has never released a warning about the potential risks of its Johnson’s Baby Powder and Shower To Shower products.

Three state court juries have decided that Johnson & Johnson should be held accountable for hiding decades of medical evidence from the public. Several plaintiffs have already been awarded millions of dollars in compensation and lawsuit numbers are continuing to grow. Most of the filed cases are pending in a Missouri federal court, while others have been filed in New Jersey, where Johnson & Johnson is headquartered.

Banville Law has many years of experience fighting large pharmaceutical companies who have put dangerous drugs and devices onto the market, foregoing public safety for corporate greed.

The firm is looking to assist those who believe they have been directly affected by the use of Johnson’s talcum powder. Affected individuals may be entitled to financial compensation and legal action. Banville Law is currently offering free consultations to individuals who qualify.

For more information, to schedule a consultation or to ask questions contact Banville Law at (888) 976-6742.

###

Contact TheProductLawyers.com:

Banville Law
888-478-9711
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023

ReleaseID: 60012457

September 28, 2016 – – TheProductLawyers.com reports on a wrongful death lawsuit filed in St. Clair County Circuit Court on November 20th, 2015 under case number 15-L-670. The plaintiffs, in this case, are comprised of 10 people living in different states claiming that family members died from excessive bleeding from taking Xarelto. Their suit is against the manufacturers of Xarelto, Bayer AG and Janssen Pharmaceuticals, the last of which is a subdivision of the Johnson and Johnson Corporation.

Xarelto lawsuits now exceed 3,000 cases, with 2,800 being consolidated in a federal court in Louisiana and an additional 550 in Philadelphia, PA that have been joined together in a mass tort program.

The plaintiffs also allege that Janssen and Bayer misled the public through its marketing and advertising which utilized celebrities to endorse and discuss the product. The plaintiffs state the manufacturers falsely represented the drug and did not sufficiently mention the potentially dangerous side effects that could result from taking it. Despite research done by the defendants that may have shown otherwise, the court filings suggest that Bayer and Janssen clearly chose to market Xarelto as an effective and safe treatment for patients who required knee and hip replacements or for those who suffered from a common heart ailment called atrial fibrillation.

In June 2013, the U.S. Food and Drug Administration contacted Bayer and Janssen via written correspondence stating that the public claims made in their advertising and marketing were not accurate. However, despite the FDA’s concern as expressed in its letter, the drug continued to be promoted as it had been with no changes made to the marketing strategy by the defendants.

The plaintiffs in the St. Clair County Circuit Court filing are requesting a minimum of $50,000 for each family member that had died to cover medical bills, funeral costs, legal fees and compensation for pain and suffering endured by those family members left behind. Janssen and Bayer are being charged with 9 counts of various charges ranging from fraud to wrongful death.

The attorneys of Banville Law, the firm behind TheProductLawyers.com, are offering complimentary consultations to anyone who suffered injury or hospitalization after a bleed while on Xarelto. For more information about this release or the Xarelto litigation call 888-478-9711.

###

Contact TheProductLawyers.com:

Banville Law
888-478-9711
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023

ReleaseID: 60012356

Ultrafast CT Scan Devices Market Assessment Report Now Available at Credence Research

Credence Research has recently issued a new market assessment report titled “Ultrafast CT Scan Devices – Growth, Future Prospects and Competitive Analysis, 2016 – 2022”. The global Ultrafast CT Scan Devices Market study provides a comprehensive view of the ongoing and future phases of the Ultrafast CT Scan Devices industry based on parameters such as major commercial events, research initiatives, government guidelines, market drivers, restraints and opportunities and detailed industry segmentation and regional distribution.

Browse the report at http://www.credenceresearch.com/report/ultrafast-ct-scan-devices-market

Based on geographic/regional distribution the global Ultrafast CT Scan Devices Market is studied for key regional markets focusing on the respective geographic trends and statistics, and thereby delivering market size and forecast values. The Ultrafast CT Scan Devices Market based on geographic classification is studied for North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa markets. Among these, the North America, Europe and Asia-Pacific Ultrafast CT Scan Devices Market is studied for top country-level markets. The Ultrafast CT Scan Devices industry in each individual country market is studied based on parameters such as per capita income, population, gross domestic product (GDP), status of infrastructure, purchasing power parity, etc. Technology development, industry concentration, end-user preference, and similar such grounds are also considered while estimating the market for Ultrafast CT Scan Devices. The market estimates are provided for the period 2014-2022, along with corresponding compounded annual growth rates (CAGRs) for the forecast period 2016-2022.

This report on Ultrafast CT Scan Devices Market also offers competition assessment tools such as market positioning of key players, attractive investment proposition, and Porter’s Five Forces model to give the readers a view of the competitive scenario of the Ultrafast CT Scan Devices Market. The Ultrafast CT Scan Devices Market report is concluded with company profiles chapter. This section highlights major information about the key players engaged in development, manufacture, distribution and sale of Ultrafast CT Scan Devices in the international markets.

Browse the report at http://www.credenceresearch.com/report/ultrafast-ct-scan-devices-market

Major extracts from the Table of Content of Ultrafast CT Scan Devices Market, 2016-2022 report:

Ultrafast CT Scan Devices Market Dynamics – Drivers, Challenges, Opportunities

Ultrafast CT Scan Devices Market Size and Forecast for the Period 2014-2022

Ultrafast CT Scan Devices Market CAGR for the Period 2016-2022

Ultrafast CT Scan Devices Market Competitive Analysis, by Key Players

Ultrafast CT Scan Devices Market: Attractive Investment Proposition, by Geography

Ultrafast CT Scan Devices Market: Key Commercial Events

Ultrafast CT Scan Devices Market: Future Prospects (upcoming product approvals)

Company Profiles

Latest Reports:

Injection Molded Plastic Market Size, Segmentation, Opportunities, Trends, Growth and Industry Forecast To 2022

Breast Pumps Market By Products (Manual Pumps, Electric/Battery Powered Pumps), Technology (Closed, Open System) – Growth, Share, Opportunities & Competitive Analysis, 2016 – 2022

Orthopedic Prosthetic Devices Market Size, Segmentation, Opportunities, Trends, Growth and Industry Forecast To 2022

About Us:

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Who we are

Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals.

Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa.

Our firm is intended to work as one. We are a solitary global research organization united by a solid arrangement of qualities, concentrated on customer effect.

What we do

We serve customers at each level of their organization, in whatever limit we can be most helpful, whether as a trusted counsel to top management or as a hands-on mentor for forefront representatives. For each engagement, we collect a group with the most suitable experience and ability.

No matter the challenge, we concentrate on delivering functional and persevering results, and preparing our customers to develop and lead. We join forces with customers to place suggestions into practice. Our research specialist work straightforwardly with customers over long stretches to create workforce aptitudes, drive operational change, and apply new working strategies.

Contact:

Name: Chris Smith

Designation: Global Sales Manager

E-mail: sales@credenceresearch.com

Ph: 1-800-361-8290

Web:  Credence Research

The post Global Ultrafast CT Scan Devices Market Size, Share,Trends, Growth and Forecast To 2022 – Credence Research appeared first on PDF Devices – eReaders and Tablets.

ReleaseID: 3469

The latest market report published by Credence Research, Inc. “Global Ultrasound Devices Market – Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 – 2022,” the ultrasound devices market was valued at USD 5,524.5 Mn in 2015, and is expected to reach USD 7,805.9 Mn by 2022, expanding at a CAGR of 5.02% from 2016 to 2022.

Browse the full report Ultrasound Devices Market – Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 – 2022 report at http://www.credenceresearch.com/report/ultrasound-devices-market

Market Insights

Ultrasound diagnosis is an imaging procedure carried out using high-frequency sound waves to produce precise images of structures of human body. The produced images during an ultrasound examination provide valuable information for diagnosis and treatment of several diseases. Introduction of innovative technologies such as 3D and 4D imaging are creating opportunities for the existing as well as new market players in ultrasound devices market.

However, the major factors restraining the growth of the market are reimbursement policies in emerging nations. The ultrasound devices market is segmented on the basis of product type, technology, application and geography. The cart/trolley based ultrasound devices segment accounted for the largest share of the ultrasound market by products in 2015 due to factors such as cost-efficiency and high market penetration compared to compact/handheld devices. Based on technology, the 3-D and 4-D ultrasound segment held the largest share of the market in 2015 and is expected to dominate the market throughout the forecast period and is likely to expand at a high CAGR from 2015 to 2023.

The overall market growth of ultrasound technology market is attributed by the use of 2D ultrasound in diagnosis of disease, accessibility to important medical reimbursement especially in mature markets, constant technological developments in the diagnostic ultrasound imaging industry, and expansion of application perspective of 3D and 4D ultrasound applications.

Market Competition Assessment

The key market leaders in ultrasound devices market are GE Healthcare, FUJIFILM Holdings Corporation, Koninklijke Philips N.V., Mindray Medical Corporation, Esaote SpA, and Analogic Corporation. Other players involved in the ultrasound devices market are Hitachi Medical Corporation, Samsung Medison Co. Ltd., Toshiba Medical Systems Corporation, Thermo fisher scientific and Siemens Healthcare. Thus, the well established companies with huge capital reserves and strong research and development are expected to dominate the market throughout the forecast period.

Browse the full report Ultrasound Devices Market – Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 – 2022 report at http://www.credenceresearch.com/report/ultrasound-devices-market

Key Market Movements

High prevalence and increasing incidence rate of oncology, cardiovascular, and other lifestyle diseases across the world
Increasing healthcare expenditure in developed as well as developing countries
Rapidly aging global population accompanied with increased health care needs

Latest Reports:

Aspergillosis Treatment: Market Growth, Future Prospects & Competitive Analysis, 2016-2023

Amyloidosis Therapeutic Treatment: Market Growth, Future Prospects & Competitive Analysis, 2016-2023

Diabetic Footwear Market Size, Segmentation, Opportunities, Trends, Growth and Industry Forecast To 2023

About Us:

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Who we are

Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals.

Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa.

Our firm is intended to work as one. We are a solitary global research organization united by a solid arrangement of qualities, concentrated on customer effect.

What we do

We serve customers at each level of their organization, in whatever limit we can be most helpful, whether as a trusted counsel to top management or as a hands-on mentor for forefront representatives. For each engagement, we collect a group with the most suitable experience and ability.

No matter the challenge, we concentrate on delivering functional and persevering results, and preparing our customers to develop and lead. We join forces with customers to place suggestions into practice. Our research specialist work straightforwardly with customers over long stretches to create workforce aptitudes, drive operational change, and apply new working strategies.

Contact:

Name: Chris Smith

Designation: Global Sales Manager

E-mail: sales@credenceresearch.com

Ph: 1-800-361-8290

Web:  Credence Research

The post Global Ultrasound Devices Market is Expected to Reach USD 7,673.8 Mn by 2022 – Credence Research appeared first on PDF Devices – eReaders and Tablets.

ReleaseID: 3463

According to the latest report published by Credence Research, Inc. “Global Sleep Apnea Devices Market – Growth, Opportunities, Competitive Analysis, and Forecast, 2016 – 2022,” the sleep apnea devices market was valued at USD 3,942.5 Mn in 2015, and is expected to reach USD 6,868.4 Mn by 2022, expanding at a CAGR of 8.1% from 2016 to 2022.

Browse the full report Global Sleep Apnea Devices Market – Growth, Opportunities, Competitive Analysis, and Forecast, 2016 – 2022 report at http://www.credenceresearch.com/report/sleep-apnea-devices-market

Market Insights

Sedentary lifestyle and associated lifestyle disorders, and rising prevalence of obstructive sleep apnea will contribute to fair growth of global sleep apnea devices market. Intensive R&D activities in developing advanced therapeutic devices and home-care solutions demonstrate lucrative future prospects for the global sleep apnea devices market.

At present, the demand for home sleep testing methods is consistently growing due added advantages such as ergonomic design of respective devices and user-friendly features for use at comfort of home. Persistent product development, commercialization of advanced products, and growth in awareness about sleep apnea and related health hazards are the prime factors contributing to the demand for sleep apnea devices market. However, lack of patient compliance in home-use high costs of sleep apnea diagnosis are some of the aspects that may hold back the desired market growth.

Currently, therapeutic devices hold the larger market share in the overall sleep apnea devices market. Innovation and cost effective product development play a critical role in the growth of this segment. Introduction of portable CPAP devices and cheaper oral devices have urged the emergence of home treatment for sleep apnea, thus opening lucrative avenue for sleep apnea devices market. Development of customized treatment devices is expected to be a key opportunity in the overall sleep apnea therapeutic devices market.

Browse the full report Global Sleep Apnea Devices Market – Growth, Opportunities, Competitive Analysis, and Forecast, 2016 – 2022 report at http://www.credenceresearch.com/report/sleep-apnea-devices-market

The global sleep apnea devices market is highly fragmented with several players scattered around various segments of the market. Regional players also have a considerable presence in the respective markets. Some of the major players active in the global sleep apnea devices market are Respironics, CareFusion, GE Healthcare, Fisher & Paykel Healthcare and others.

Latest Reports:

Injection Molded Plastic Market Size, Segmentation, Opportunities, Trends, Growth and Industry Forecast To 2022

Ultrafast CT Scan Devices Market Size, Segmentation, Opportunities, Trends, Growth and Industry Forecast To 2022

Orthopedic Prosthetic Devices Market Size, Segmentation, Opportunities, Trends, Growth and Industry Forecast To 2022

About Us:

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Who we are

Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals.

Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa.

Our firm is intended to work as one. We are a solitary global research organization united by a solid arrangement of qualities, concentrated on customer effect.

What we do

We serve customers at each level of their organization, in whatever limit we can be most helpful, whether as a trusted counsel to top management or as a hands-on mentor for forefront representatives. For each engagement, we collect a group with the most suitable experience and ability.

No matter the challenge, we concentrate on delivering functional and persevering results, and preparing our customers to develop and lead. We join forces with customers to place suggestions into practice. Our research specialist work straightforwardly with customers over long stretches to create workforce aptitudes, drive operational change, and apply new working strategies.

Contact:

Name: Chris Smith

Designation: Global Sales Manager

E-mail: sales@credenceresearch.com

Ph: 1-800-361-8290

Web:  Credence Research

The post Global Sleep Apnea Devices Market is Expected Expanding at a CAGR of 8.1% from 2016 to 2022 appeared first on PDF Devices – eReaders and Tablets.

ReleaseID: 3465